MK
Manvendra Kumar
Amity University Uttar Pradesh, Central University of Punjab, Integral Biosciences Pvt Ltd
Employment
-
Amity University Uttar Pradesh Assistant Professor2026 - Present
-
Central University of Punjab Senior Research Fellow2021 - 2024
-
Central University of Punjab Junior Research Fellow2019 - 2021
-
Integral Biosciences Pvt Ltd Drug design, synthesis, purification of compounds2016 - 2019
Education
-
Central University of Punjab PhD2019 - 2025
Projects & Funding
Projects & funding information is unavailable.
Publications (13)
- Synthesis of New Substituted 5H-Benzo[e]imidazo[1,2-a][1,4]diazepines via Pictet–Spengler Reaction and Their Neuroprotective and Anticonvulsant Evaluation Save
- Design and Synthesis of Topoisomerases-Histone Deacetylase Dual Targeted Quinoline-Bridged Hydroxamates as Anticancer Agents Save
- Imidazo[1,2‐a]Quinoxaline‐2‐Carbonitrile Derivative (RA‐22) Inhibits Self‐Renewal and Growth of Cancer Stem and Cancer Cells via Downregulating AKT Pathway Save
- Synthetic Modifications of Therapeutically Relevant Pre-assembled Cucurbitacins: Synthetic Strategies and Structure-Activity Relationships Save
- Design, synthesis, and anticancer assessment of structural analogues of (E)-1-((3,4,5-trimethoxybenzylidene)amino)-4-(3,4,5-trimethoxyphenyl)imidazo[1,2-a]quinoxaline-2-carbonitrile (6b), an imidazo[1,2-a]quinoxaline-based non-covalent EGFR inhibitor Save
- Synthetic Approaches and Reactions of 2-(Arylidene)benzo[b]thiophen-3(2H)one-1,1-dioxides Save
- Targeting the Epidermal Growth Factor Receptor with Molecular Degraders: State-of-the-Art and Future Opportunities Save
- In Vivo Anticancer Evaluation of 6b, a Non-Covalent Imidazo[1,2-a]quinoxaline-Based Epidermal Growth Factor Receptor Inhibitor against Human Xenograft Tumor in Nude Mice Save
- Design and Synthesis of Non-Covalent Imidazo[1,2-a]quinoxaline-Based Inhibitors of EGFR and Their Anti-Cancer Assessment Save
- Epidermal Growth Factor Receptor and its trafficking regulation by acetylation: Implication in resistance and exploring the newer therapeutic avenues in cancer Save